Microbot Medical Inc (MBOT)
Microbot Medical Inc. is a healthcare equipment and supplies company focused on robotic technology for endovascular procedures. The company’s LIBERTY system is designed to let physicians perform catheter-based interventions remotely from outside the catheterization laboratory, with the aim of reducing radiation exposure, physical strain, and cross-contamination risk in cardiovascular, peripheral, endovascular, and neurovascular procedures. Microbot Medical also develops NovaCross, a technology platform for intraluminal revascularization devices that incorporates an anchoring mechanism and an integrated microcatheter. The company has collaboration agreements with Corewell Health for LIBERTY development and with Emory University relating to autonomous robotics in endovascular procedures. Founded in 2010, Microbot Medical is based in Hingham, Massachusetts, and its common stock trades on NASDAQ under the symbol MBOT.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-MBOT
|
$1.42
|
4.1% Upside
|
Fair
|
$6.67
|
390.2% Upside
|
Bargain
|
Fair
|
0.0%
|
November 6, 2026
|
1.4x
|
275.6x
|
91.344 M
|
28.883 M
|
0.9%
|
100.0%
|
11.0
|
109.7%
|
